John Green vs. Johnson & Johnson (part 1) – An Arm And a Leg
Why writer John Green rallied his fans around a fight over the cost of a tuberculosis drug.
Why writer John Green rallied his fans around a fight over the cost of a tuberculosis drug.
UroToday – GU OncToday brings coverage of the clinically relevant content needed to stay at the forefront of the dynamic field of GU oncology and…
Clinics, patients and abortion rights activists in Florida are bracing for the impact of a six-week abortion ban that will significantly curtail access in the…
Zach Klaassen and Alexander Cole discuss the impact of climate change on cancer screening, highlighting a study that explores public awareness of climate change’s health…
Breast cancer cases are increasing among younger women, which means it now makes sense to start regular screening younger, a federal task force says.
Ruchika Talwar hosts Natasha Gupta to explore the overlooked perspective of female partners in prostate cancer care. Dr. Gupta delves into her study on the…
A federal program that helped pay for more than 23 million low-income households’ internet access runs out of money soon. The end of the subsidy…
Get the most up-to-date outbreak information here.
Renal Cell Carcinoma (RCC), Advanced Renal Cell Carcinoma, vascular endothelial growth factor receptor (VEGF-R), Axitinib, adverse events of Axitinib treatment, mTOR inhibitors, tyrosine kinase inhibitors…
Zach Klaassen facilitates a conversation on the continuum of care in metastatic hormone-sensitive prostate cancer (mHSPC) with Jason Hafron and Elisabeth Heath. The discussion underscores…
“Health Minute” brings original health care and health policy reporting from the KFF Health News newsroom to the airwaves each week.